Study details
Enrolling now
PSMA PET Response Guided SabR in High Risk Prostate Cancer
University of Texas Southwestern Medical Center
NCT IDNCT06044857ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
20
Study length
about 2.7 years
Ages
18–99
Sex
Male only
Locations
2 sites in TX
What this study is about
This trial is testing a new treatment approach for prostate cancer. It involves using PSMA PET imaging to guide the timing of radiation therapy (SabR). The goal is to determine the best time to give radiation to achieve the most effective response.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take 68-Ga PSMA11
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.